Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2026-05-02 @ 5:01 PM
Study NCT ID:
NCT04501666
Status:
COMPLETED
Last Update Posted:
2024-07-10
First Post:
2020-07-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)
Sponsor:
Galderma R&D
Organization: